Bionano Genomics To Acquire Purigen Biosystems To Enable Further Simplified And Accelerated Dna Isolation For Optical Genome Mapping (Ogm) And Address Difficult Sample Types In New Applications With Isotachophoresis (Itp) On The Ionic Purification System
Acquiring Company
Bionano Genomics
Acquired Company
Purigen Biosystems, Inc.
San DiegoPleasantonBiotechnologyHealthcareSoftwareHealth CareGeneticsBioinformaticsBiotechnologyDescription
Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that it has entered into a definitive agreement to acquire Purigen Biosystems, Inc. (Purigen), a company that develops and commercializes automated nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology, which was licensed exclusively from Stanford and developed by Purigen. Purigen’s ITP technology is a solution-based purification approach and therefore different from protocols in routine use today, which tend to rely on binding to a matrix, washing and then removal from the matrix. Those protocols are less efficient at capturing molecules from dilute solutions or from samples with small amounts of cells and often result in shorter average lengths of DNA than what optical genome mapping (OGM) requires. The transaction is expected to accelerate the adoption of OGM due to anticipated improvements in its ultra high molecular weight (UHMW) DNA sample preparation workflow.
Other recent acquisitions in Healthcare and Genetics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Solid Biosciences Announces Closing Of Acquisition Of Aavantibio And Concurrent $75 Million Private Placement, $75M (December 5, 2022)
- Solid Biosciences Announces Stockholder Approval Of Acquisition Of Aavantibio (December 1, 2022)
- Merck Completes Tender Offer To Acquire Imago Biosciences, Inc. (January 11, 2023)
- Prenetics Acquires Act Genomics, Creating A Leader In Comprehensive Cancer Genetics And Precision Oncology (December 16, 2022)
- Rocket Pharmaceuticals Completes Acquisition Of Renovacor (December 1, 2022)
- Merck To Acquire Imago Biosciences, Inc. (November 21, 2022)
Who to call at Bionano Genomics, and when
When Bionano Genomics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Bionano Genomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bionano Genomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bionano Genomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bionano Genomics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Purigen Biosystems, Inc.?
Purigen Biosystems, Inc. was acquired by Bionano Genomics, based in San Diego. The deal was reported on November 28, 2022. At Bionano, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. Bionano Genomics is publicly traded (BNGO) and operates in Biotechnology.
When did Bionano Genomics acquire Purigen Biosystems, Inc.?
Bionano Genomics's acquisition of Purigen Biosystems, Inc. was reported on November 28, 2022. Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that it has entered into a definitive agreement to acquire Purigen Biosystems, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Purigen Biosystems, Inc. do?
Purigen Biosystems develops an isotachophoresis chip for nucleic acid preparation. It is privately held, operating in Biotechnology, and is based in Pleasanton.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.